ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
A Medication Adherence Intervention for HIV Infected Veterans

This study has been completed.

Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00013065
  Purpose

It is estimated that the VHA is caring for nearly 40 percent of all HIV-infected veterans. To benefit from recent improvements in anti-HIV therapy, patients need to take their medications consistently.


Condition
HIV Infection

MedlinePlus related topics:   AIDS   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Prospective
Official Title:   A Medication Adherence Intervention for HIV Infected Veterans

Further study details as provided by Department of Veterans Affairs:

Estimated Enrollment:   210
Study Completion Date:   December 2003

Groups/Cohorts
1

Detailed Description:

Background:

It is estimated that the VHA is caring for nearly 40 percent of all HIV-infected veterans. To benefit from recent improvements in anti-HIV therapy, patients need to take their medications consistently.

Objectives:

Optimizing health for HIV patients requires excellent adherence to antiretroviral medication regimens. However, its unclear how best to incorporate adherence education and support programs into VA HIV outpatient care. We implemented and evaluated a pharmacist program (ACE) and a Pager reminder program to support adherence in veterans with HIV.

Methods:

We used a quasi-experimental design with pre-post evaluation at four VA Centers. Three treatment conditions (ACE, Pager, Usual Care) were rolled-in sequentially over two study phases, allowing for group comparisons between conditions. ACE is a multi-component manualized 4-session, individual patient education and support program by trained pharmacists. The Pager intervention used alphanumeric pagers to remind patients of dosing times. Electronically-monitored medication adherence (MEMS), self-report questionnaires, and pharmacy refill records were collected. Qualitative site interviews were collected before and after interventions to assist with program evaluation. Multilevel mixed models were used to analyze main study outcomes over time. Secondary analyses compared subgroup who actually received all ACE sessions (�as treated�) to controls.

Status:

Project has been completed and Final Report submitted to HSR&D CO.

  Eligibility
Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

Patients must be greater than or equal to 18 years old, must be enrolled in HIV Primary care at one of 4 VA study sites and be taking antiretroviral therapy.

Exclusion Criteria:

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00013065

Locations
United States, Arizona
Southern Arizona VA Health Care System    
      Tucson, Arizona, United States, 85723-0001
United States, California
VA Greater Los Angeles Healthcare System, West LA    
      Los Angeles, California, United States, 90073-1002
VA Palo Alto Health Care System    
      Palo Alto, California, United States, 94304-1207
VA San Diego Health Care System    
      San Diego, California, United States, 92161
United States, Massachusetts
Edith Nourse Rogers Memorial Veterans Hospital, Be    
      Bedford, Massachusetts, United States, 01730

Sponsors and Collaborators

Investigators
Principal Investigator:     Allen L. Gifford, MD     Edith Nourse Rogers Memorial Veterans Hospital, Be    
  More Information

Publications of Results:

Responsible Party:   Department of Veterans Affairs ( Gifford, Allen - Principal Investigator )
Study ID Numbers:   HII 99-054
First Received:   March 14, 2001
Last Updated:   August 14, 2008
ClinicalTrials.gov Identifier:   NCT00013065
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Virus Diseases
Sexually Transmitted Diseases, Viral
HIV Infections
Sexually Transmitted Diseases
Acquired Immunodeficiency Syndrome
Retroviridae Infections
Immunologic Deficiency Syndromes

Additional relevant MeSH terms:
RNA Virus Infections
Slow Virus Diseases
Immune System Diseases
Lentivirus Infections
Infection

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers